Abstract
A double-blind and randomized clinical trial, which included 48 patients with postoperative intestinal paralysis on the third day after laparotomy, demonstrated no difference between treatment with ceruletide (0.3 μg/kg body weight) and neostigmine (5.0 μg/kg body weight) in restoring normal intestinal function.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Agosti A, Bertaccini G, Paulucci R, Zanella E. Caerulein treatment for paralytic ileus. Lancet 1971;1:395.
Haas W, Rueff FL. Caerulein in der Therapie der postoperativen Darmatonie und des Ileus. Therapiewoche 1978;28:8939–44.
Sommoggy S, Theisinger W, Fraunhofer B. Medikamentoese Beeinflussung der postoperativen Darmatonie. Fortschr Med 1981;99:13–21.
Madsen PV, Lykkegaard-Nielsen M, Nielsen OV. Ceruletide reduces postoperative intestinal paralysis: a double-blind placebocontrolled trial. Dis Colon Rectum 1983;26:159–60.
Lykkegaard-Nielsen M, Madsen PV, Nielsen OV. Ceruletide vs. metoclopramide in postoperative intestinal paralysis: a double-blind clinical trial. Dis Colon Rectum 1984;27:288–9.
Wilson JP. Postoperative motility of the large intestine in man. Gut 1975;16:689–92.
Woods JH, Erickson LW, Condon RE, Schulte WJ, Sillin LF. Postoperative ileus: a colonic problem? Surgery 1978;84:527–33.
Carmichael EA, Fraser FR, McKelvey D, Wilkie DP. The therapeutic action of Prostigmin. Lancet 1934;1:942–5.
Editorial. Postoperative ileus. Lancet 1978;2:1186–7.
Author information
Authors and Affiliations
About this article
Cite this article
Madsen, P.V., Olsen, O. & Hagen, K. Ceruletide and neostigmine in postoperative intestinal paralysis. Dis Colon Rectum 29, 712–713 (1986). https://doi.org/10.1007/BF02555315
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02555315